SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-056408
Filing Date
2015-06-25
Accepted
2015-06-25 17:33:07
Documents
2
Period of Report
2015-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2791
2 EX-24 DOCUMENT attachment1.htm EX-24 4292
  Complete submission text file 0001209191-15-056408.txt   8572
Mailing Address C/O MERCK & CO., INC. ONE MERCK DRIVE, WS2A-40 WHITEHOUSE STATION NJ 08889
Business Address
Kender Richard N (Reporting) CIK: 0001381205 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 15952581

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations